Showing results (1011-1020 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|November 16, 2011
Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survivalDeborah Wilsker, Jon H Chung, Ivan Pradilla, et al.
Molecular Cancer Therapeutics|November 16, 2011
MK1775, a selective Wee1 inhibitor, shows single-agent antitumor activity against sarcoma cellsJenny M Kreahling, Jennifer Y Gemmer, Damon Reed, et al.
Molecular Cancer Therapeutics|September 29, 2011
Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activityDeliang Cao, Amy Ziemba, James McCabe, et al.
Molecular Cancer Therapeutics|September 15, 2011
The Bcl-2/Bcl-X(L)/Bcl-w inhibitor, navitoclax, enhances the activity of chemotherapeutic agents in vitro and in vivoJun Chen, Sha Jin, Vivek Abraham, et al.
Molecular Cancer Therapeutics|September 14, 2011
Inhibition of SAPK2/p38 enhances sensitivity to mTORC1 inhibition by blocking IRES-mediated translation initiation in glioblastomaCheri Cloninger, Andrew Bernath, Tariq Bashir, et al.
Molecular Cancer Therapeutics|September 6, 2011
3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesisDharmalingam Subramaniam, Nathan D Nicholes, Animesh Dhar, et al.
Molecular Cancer Therapeutics|November 22, 2011
An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosisHideaki Hanaki, Hideki Yamamoto, Hiroshi Sakane, et al.
Molecular Cancer Therapeutics|June 11, 2011
Melanoma prognosis: a REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studiesSarah-Jane Schramm, Graham J Mann
Molecular Cancer Therapeutics|May 27, 2011
High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasionLaura Muinelo-Romay, Eva Colas, Jorge Barbazan, et al.
Molecular Cancer Therapeutics|May 27, 2011
Berberine suppresses androgen receptor signaling in prostate cancerJing Li, Bo Cao, Xichun Liu, et al.
Pageof 599